Sajulga, Emma .

HRN: 22-98-15  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2025
CEFUROXIME 1.5GM (VIAL)
02/25/2025
02/26/2025
IV
1.5g
PTOR
PTOR
Waiting Final Action 
02/25/2025
CEFUROXIME 500MG (TAB)
02/25/2025
03/04/2025
ORAL
500 Mg/tab
Bid
S/p Endometrial Curettage
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: